Management of Kaposi's sarcoma. Chemotherapy I.
D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011929:Razoxane / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D007166:Immunosuppressive Agents; D014748:Vinca Alkaloids; D003609:Dactinomycin; D011929:Razoxane; D002330:Carmustine; D011241:Prednisone